Skip to content

Efficacy and Safety of tranexamic acid in Spine surgery

Efficacy and Safety of tranexamic acid in Spine surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022076
Enrollment
Unknown
Registered
2019-03-23
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar spinal stenosis

Interventions

Group A:carbacycloic acid

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Stenosis of single segment and bilateral spinal canal was confirmed by imaging examination. 2. all patients had symptoms of nerve compression and intermittent claudication, which showed radiation pain of unilateral or bilateral lower extremities, numbness and powerlessness, and no improvement of symptoms for more than 3 months after regular conservative treatment

Exclusion criteria

Exclusion criteria: 1. The patient with injury of cauda equina nerve, dysuria of urine and stool; 2. ossification of posterior longitudinal ligament, developmental spinal stenosis, lumbar spondylolisthesis; 3. cardio-pulmonary causes, and so on.

Design outcomes

Primary

MeasureTime frame
Intraoperative blood loss;Total blood loss;Total blood transfusion;Ratio of blood transfusions (intraoperative and postoperative transfusions);

Contacts

Public ContactQingquan Kong

West China Hospital, Sichuan University

kqqspine@126.com+86 18980601954

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026